Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Hyperglycemia increases the risk of cardiovascular disease: epidemiological evidence

July 22, 1997

D1/D2 combination therapy results reported at the 16th IDF congress

July 22, 1997

RPR seeks approval for Menorest in Japan

July 22, 1997

U.S. patent allowance for Cypress Bioscience's IPM product

July 22, 1997

Steroids from Jenapharm for contraception/HRT

July 22, 1997

New treatment in development for Pompe's disease

July 21, 1997

Once-daily atorvastatin vs. pravastatin for hypercholesterolemia

July 16, 1997

Senetek files third PLA for INVICORP

July 16, 1997

Mianserin studied for treatment of sexual dysfunction

July 16, 1997

New oral antidiabetic agents disclosed

July 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...